Cabaletta Bio (NASDAQ:CABA) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.39) by 17.95 percent. This is a 188.46 percent decrease over earnings of $0.52 per share from the same period last year.
Cabaletta Bio Q4 EPS $(0.46) Misses $(0.39) Estimate; Cabaletta Had Cash, Cash Equivalents And Short-term Investments Of $241.2M Expected To Fund Its Operating Plan Into The First Half Of 2026
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.